×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
📊
Experiments
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
Vision
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
Vision
Showcase
Demo
←
Home
/
Wiki
/
Clinical: Olfactory Mucosa, Blood and Urine for Identification of Earl
clinical
1,624 words
KG: Olfactory Mucosa, Blood and Urine for Identification of Early Neurodegeneration (NCT06846658)
2026-03-28
kind:clinical-trial
section:clinical-trials
state:published
topic:parkinsons
topic:psp
topic:biomarkers
Contents
Olfactory Mucosa, Blood and Urine for Identification of Early Neurodegeneration (NCT06846658)
Knowledge Graph
Related Hypotheses (30)
SASP-Mediated Complement Cascade Amplification
Score: 1.00
Nutrient-Sensing Epigenetic Circuit Reactivation
Score: 0.97
Selective Acid Sphingomyelinase Modulation Therapy
Score: 0.96
Transcriptional Autophagy-Lysosome Coupling
Score: 0.95
CYP46A1 Overexpression Gene Therapy
Score: 0.94
Circadian Glymphatic Entrainment via Targeted Orexin Recepto
Score: 0.90
Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.88
Senescence-Activated NAD+ Depletion Rescue
Score: 0.87
SASP-Driven Aquaporin-4 Dysregulation
Score: 0.86
Digital Twin-Guided Metabolic Reprogramming
Score: 0.86
AMPK hypersensitivity in astrocytes creates enhanced mitocho
Score: 0.85
Multi-Modal Stress Response Harmonization
Score: 0.84
Competitive APOE4 Domain Stabilization Peptides
Score: 0.84
Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu
Score: 0.84
SASP-Mediated Cholinergic Synapse Disruption
Score: 0.84
Circadian-Synchronized Proteostasis Enhancement
Score: 0.83
Selective HDAC3 Inhibition with Cognitive Enhancement
Score: 0.83
Chromatin Accessibility Restoration via BRD4 Modulation
Score: 0.83
Smartphone-Detected Motor Variability Correction
Score: 0.82
APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.82
Senescent Microglia Resolution via Maresins-Senolytics Combi
Score: 0.82
Senescent Cell Mitochondrial DNA Release
Score: 0.81
Glymphatic System-Enhanced Antibody Clearance Reversal
Score: 0.81
Synthetic Biology BBB Endothelial Cell Reprogramming
Score: 0.81
Blood-Brain Barrier SPM Shuttle System
Score: 0.80
Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.80
Circadian Clock-Autophagy Synchronization
Score: 0.80
Adenosine-Astrocyte Metabolic Reset
Score: 0.80
Retinal Vascular Microcirculation Rescue
Score: 0.79
Senescence-Induced Lipid Peroxidation Spreading
Score: 0.79
Show 25 more
Related Analyses (30)
Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived
Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived
Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived
Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived
Mitochondrial transfer between neurons and glia
neurodegeneration · archived
Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed
Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived
Synaptic pruning by microglia in early AD
neurodegeneration · archived
Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived
Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived
Perivascular spaces and glymphatic clearance failure in AD
neurodegeneration · archived
Epigenetic reprogramming in aging neurons
neurodegeneration · archived
Extracellular vesicle biomarkers for early AD detection
neurodegeneration · archived
Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · archived
Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · archived
Senescent cell clearance as neurodegeneration therapy
neurodegeneration · archived
Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived
SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas
neurodegeneration · completed
Mechanistic role of APOE in neurodegeneration
neurodegeneration · archived
Circuit-level neural dynamics in neurodegeneration
neuroscience · archived
Immune atlas neuroinflammation analysis in neurodegeneration
Neuroinflammation · archived
Show 25 more
Related Experiments (30)
Animal Model Comparison for Neurodegenerative Disease Therap
clinical · proposed · Score: 0.40
Endocannabinoid System Dysfunction Validation in Parkinson's
clinical · proposed · Score: 0.40
ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40
Glymphatic-Circadian Axis Enhancement Therapy for Parkinson'
clinical · proposed · Score: 0.40
Cytochrome Therapeutics
clinical · proposed · Score: 0.40
Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag
clinical · proposed · Score: 0.40
Neural Oscillation Dysfunction Validation in Parkinson's Dis
clinical · proposed · Score: 0.40
Oligodendrocyte-Myelin Dysfunction Validation in Parkinson's
clinical · proposed · Score: 0.40
Proteasome-Ubiquitin System Dysfunction Validation in Parkin
clinical · proposed · Score: 0.40
Protein Aggregation Kinetic Validation Results
validation · proposed · Score: 0.40
Purinergic Signaling Dysfunction Validation in Parkinson's D
clinical · proposed · Score: 0.40
Regulated Necrosis Validation Study in Parkinson's Disease
clinical · proposed · Score: 0.40
Stress Granule Dysfunction Validation in Parkinson's Disease
clinical · proposed · Score: 0.40
Experiment Validation: In vitro ThT Assay
validation · proposed · Score: 0.40
Proposed experiment from debate on Astrocytes adopt A1 (neur
falsification · proposed · Score: 0.40
s:** - Biochemical binding assays measuring PROTAC selectivi
falsification · proposed · Score: 0.40
Proposed experiment from debate on Epigenetic clocks and bio
falsification · proposed · Score: 0.40
Proposed experiment from debate on Microglia activate astroc
falsification · proposed · Score: 0.40
Proposed experiment from debate on Astrocytes adopt A1 (neur
falsification · proposed · Score: 0.40
Proposed experiment from debate on Epigenetic clocks and bio
falsification · proposed · Score: 0.40
s:** - Temporal analysis showing mitochondrial defects prece
falsification · proposed · Score: 0.40
s:** - Test MCU overexpression specifically in layer II neur
falsification · proposed · Score: 0.40
Proposed experiment from debate on TDP-43 undergoes liquid-l
falsification · proposed · Score: 0.40
Proposed experiment from debate on TDP-43 undergoes liquid-l
falsification · proposed · Score: 0.40
s:** - Compare uptake with/without magnetic particles using
falsification · proposed · Score: 0.40
Proposed experiment from debate on Perivascular spaces and g
falsification · proposed · Score: 0.40
s:** - Test tau spreading in AQP4 knockout vs wild-type mice
falsification · proposed · Score: 0.40
Proposed experiment from debate on Mitochondrial transfer be
falsification · proposed · Score: 0.40
s:** - Compare tau strain spreading in EXT1/EXT2 conditional
falsification · proposed · Score: 0.40
Proposed experiment from debate on Perivascular spaces and g
falsification · proposed · Score: 0.40
Show 25 more
See Also (15)
Yoga Therapy for Neurodegeneration
therapeutic · Pages share 139 hypotheses
YAP/TEAD Pathway Modulators for Neurodegeneration
therapeutic · Pages share 139 hypotheses
Wnt Signaling Modulators for Neurodegeneration
therapeutic · Pages share 139 hypotheses
vitamin-d-therapy-neurodegeneration
therapeutic · Pages share 139 hypotheses
Vitamin B Complex Therapy for Neurodegeneration
therapeutic · Pages share 139 hypotheses
VIP/VPAC Receptor Modulators for Neurodegeneration
therapeutic · Pages share 139 hypotheses
Urolithin A for Neurodegeneration
therapeutic · Pages share 139 hypotheses
Urolithin A for Neurodegeneration
therapeutic · Pages share 139 hypotheses
tudca-udca-neurodegeneration
therapeutic · Pages share 139 hypotheses
TRPM8 Agonists for Neurodegeneration
therapeutic · Pages share 139 hypotheses
Triple Incretin Agonists (GLP-1/GIP/Glucagon) for Neuro
therapeutic · Pages share 139 hypotheses
TREM2 Agonist Therapy for Neurodegeneration
therapeutic · Pages share 139 hypotheses
Transcranial Magnetic Stimulation Therapy for Neurodege
therapeutic · Pages share 139 hypotheses
TLR7/8/9 Antagonists for Neurodegeneration
therapeutic · Pages share 139 hypotheses
TLR4 Antagonists for Neurodegeneration
therapeutic · Pages share 139 hypotheses
Show 10 more
Knowledge Graph (1 edges)
Olfactory Mucosa, Blood and Urine for Identification of Early Neurodegeneration (NCT06846658)
references
SST